II. Special Issues 
A. Provision of accurate information to the public 
B. Timely ccmunication of research methods and results to investigators 
and clinicians 
III. Requested Documentation 
A. Original protocol 
B. IRB and IBC minutes and recommendations 
C. One-page abstract of gene therapy protocol 
D. One-page description of proposed experiment in non-technical language 
E. Curricula vitae for professional personnel 
F. Indication of other federal agencies to which the protocol is being 
submitted 
G. Other pertinent material 
IV. Reporting Requirements 
[ 120 ] 
Recombinant DNA Research, Volume 1 1 
